Products
Companies
News
About
About
Add your product
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
LungQ™ Clinical Suite
LungQ™ Clinical Suite
Thirona
Thirona’s lung quantification software offers analysis of chest CT scans based on artificial intelligence, aiding in the detection, evaluation, and treatment planning of lung diseases. Analysis provided by the software include quantifications of anatomical volumes, disease distributions, airway morphology, vascular morphology, fissure completeness, and analysis of COVID related abnormalities.
Information source:
Vendor
Last updated:
March 20, 2020
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
LungQ™ Clinical Suite
Company
Thirona
Subspeciality
Chest
Modality
CT
Disease targeted
COPD, emphysema, airtrapping, asthma, cystic fibrosis, COVID-19
Key-features
Volume segmentation and quantification, volume density analysis, airway morphology , vascular morphology, fissure completeness analysis
Suggested use
During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion, treatment planning
Technical Specifications
Data characteristics
Population
All chest CT scans
Input
Volumetric chest CT, 3D, thin slice
Input format
DICOM
Output
Html report, pdf report, JSON file, segmentation overlays, quantitative values
Output format
html, pdf, zraw, JSON
Technology
Integration
Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment
Locally on dedicated hardware
Trigger for analysis
Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
> 10 minutes
Regulatory
Certification
CE
Certified, Class IIa
, MDR
FDA
510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)
Market
Market presence
On market since
09-2016
Distribution channels
StratX, Blackford
Countries present (clinical, non-research use)
22
Paying clinical customers (institutes)
400
Research/test users (institutes)
10
Pricing
Pricing model
Pay-per-use
Based on
Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers
Five-Year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
(read)
Airway wall thickening on CT: relation to smoking status and severity of COPD
(read)
Disease Severity Dependence of the Longitudinal Association Between CT Lung Density and Lung Function in Smokers.
(read)
Predicting Lung Volume Reduction after Endobronchial Valve Therapy Is Maximized Using a Combination of Diagnostic Tools
(read)